CLEVELAND, OH. – Oct. 31, 2017—Sterigenics International LLC announced today that it has acquired Toxikon Europe N.V., the European division of Toxikon Corporation, a Bedford, Mass.-based preclinical contract research organization. Terms of the deal were not disclosed.
BALTIMORE, MD and BROADVIEW HEIGHTS, OH – October 3, 2017—Noxilizer, Inc. and Sterigenics International LLC announce the signing of a global agreement that will make Sterigenics the exclusive worldwide provider of nitrogen dioxide (NO2) contract sterilization services, as well as feasibility and research studies, to the pharmaceutical, biotech and medical device manufacturing industries.
COLUMBIA, MO, March 29, 2017—The University of Missouri Research Reactor (MURR®) and its partners Nordion, a business of Sterigenics International, and General Atomics (GA), announce that MURR’s License Amendment Request (LAR) has been submitted to the U.S. Nuclear Regulatory Commission (NRC). This marks a critical step towards implementing domestic U.S. production of molybdenum-99 (Mo-99). Once operational, production from this facility will be capable of supporting nearly half of U.S. demand for Mo-99, which currently must be imported from outside North America.
GUELPH, ON – February 23, 2017—A high-tech form of insect birth control connected to nuclear power could solve a devastating pest problem for Ontario farmers, says a University of Guelph researcher.
OTTAWA, Dec. 7, 2016 /CNW/ – Nordion, a standalone business of Sterigenics International, in partnership with General Atomics (GA), welcome today’s award by the United States Department of Energy’s (DOE) National Nuclear Security Administration (NNSA) of the Phase II cooperative agreement funding…
KANATA, ON, Nov. 8, 2016 /CNW/ – Nordion and Bruce Power have entered into an agreement to secure the long-term supply of Cobalt-60 up to 2064.
The agreement extends a previous supply arrangement that would have expired at the end of 2028 and now covers the life of the four Bruce B reactors, which will operate up to 2064 once life-extension maintenance programs are completed over the next two decades. The agreement also includes the supply of medical-grade ‘High Specific Activity’ (HSA) Cobalt…
Sterigenics International and its Subsidiary Nordion Enter into Agreement to Acquire REVISS Services
KANATA, ON – August 16, 2016 – Sterigenics International LLC and subsidiary Nordion are pleased to announce that they have entered into an agreement as part of REVISS’s Solvent Members Voluntary Liquidation to purchase REVISS Services (UK) Limited…
The role of Nordion technology in preventing the spread of the Zika virus
According to the International Atomic Energy Agency (IAEA), the global effort to combat the spread of the Zika virus is to include an important role for Cobalt-60, an isotope supplied by Nordion and produced in Bruce Power reactors.
April 4, 2016 – The Zika virus has been linked to birth defects, paralysis (Guillain-Barré syndrome) and, more recently, to a life-threatening type of brain inflammation…
Sterigenics International and Nordion welcome landmark agreement from Bruce Power and Ontario’s Independent Electricity System Operator to extend the life of six reactors, enabling continued long-term supply of Cobalt-60
Cobalt-60 is essential to the global healthcare community and this announcement showcases Ontario’s continued leadership in gamma sterilization
TORONTO – DEC. 4, 2015 – Sterigenics International LLC and subsidiary Nordion welcome the joint announcement from Bruce Power and Ontario’s Independent Electricity System Operator (IESO) to refurbish six of Ontario’s nuclear reactors…
Developing a new source of Cobalt-60 essential to global healthcare providers and patients
TORONTO – OCT. 27, 2015 – Two of Ontario’s innovative nuclear sector companies are once again building on their strong partnership and respective strengths to create a new, long-term supply of an important cancer-treating isotope, Cobalt-60, that will benefit healthcare patients in Canada and around the world…
